Press Releases

You will find all our regulatory press releases in the feed below. Enjoy and share all our other Asarina Pharma news in our regularly updated News Archive.

   

Decisions from Annual General Meeting of Asarina Pharma, 8 May 2019

(Stockholm May 8, 2019) On 8 May 2019, the Annual General Meeting (”AGM”) of Asarina Pharma AB (publ) was held in Stockholm. Read below for a summary of the decisions made.

Full PDF
   

Asarina Pharma Annual Report for 2018 released

(Stockholm April 17 2019) Asarina Pharma AB today announces that its Annual Report for 2018 is now available on the company’s website.

Full PDF
Asarina-Pharma annual-report2018-ENG
   

Asarina Pharma Proposals regarding the Board of Directors for the Annual General Meeting 2019

(April 11 2019) The following proposals (items 12-15 in the agenda) for the upcoming Annual General Meeting have been made:

Full PDF
   

NOTICE OF ANNUAL GENERAL MEETING IN ASARINA PHARMA AB (publ)

The shareholders of Asarina Pharma AB (publ) are hereby summoned to attend the Annual General Meeting (“AGM”) on May 8th, 2019, at 15.00 CET at Erik Penser Bank, Apelbergsgatan 27 in Stockholm, Sweden. Registration starts at 14.30 CET and will stop when the meeting starts. NOTE: This is an unofficial translation of the original notice,…

Full PDF
   

Asarina Pharma shows efficacy of Sepranolone in Tourette’s syndrome on par with current first line treatment, but without side effects

Stockholm, April 2, 2019: Sepranolone reduces tics in an animal model of Tourette’s syndrome on par with Haldol, without inducing any motor side effects.

Full PDF